Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes

Product Description
spectrostar-nano.gif

Experience the future of microplate reader technology today with the SPECTROstar Nano. Using an ultrafast CCD-based spectrometer, it can capture a full UV-Vis absorbance spectrum from 220 to 1000 nm in 1, 2, 5, or 10 nm increments in less than 1 second per well. Monochromators cannot match the speed or resolution of a spectrometer. In addition, it can measure a full spectrum in all microplate formats from 6- to 1536-wells, as well as low volumes (2uL) in BMG LABTECH’s LVis microplate. Full spectra of individual samples can also be assessed by using the integrated cuvette port. This port accommodates standard, micro, and ultra-low volume cuvettes for measurements of 1uL.

The SPECTROstar Nano makes absorbance measurements easy with app-style, one-click button operation and predefined protocols for the most common absorbance assays such as ELISAs, DNA, RNA, protein (Bradford, BCA, Lowry), cell growth, beta-galactosidase, MTT toxicity, enzyme kinetics, and many more.

Some of the outstanding features include:

• Ultra-fast UV/Vis spectrometer
• Spectrum 220 to 1000 nm in <1 sec/well
• Microplate formats up to 1536 wells
• Cuvette port for standard, micro and ultra-low volume cuvettes
• Low volumes down to 2 µL
• Multimode shaking and incubation
• Well scanning, kinetic and endpoint measurements
• Gas vent for atmospheric sensitive samples
• Powerful MARS Data Analysis Software
• Robot compatible
Product SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!